1. Home
  2. PTGX vs ACIW Comparison

PTGX vs ACIW Comparison

Compare PTGX & ACIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • ACIW
  • Stock Information
  • Founded
  • PTGX 2006
  • ACIW 1975
  • Country
  • PTGX United States
  • ACIW United States
  • Employees
  • PTGX N/A
  • ACIW N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • ACIW EDP Services
  • Sector
  • PTGX Health Care
  • ACIW Technology
  • Exchange
  • PTGX Nasdaq
  • ACIW Nasdaq
  • Market Cap
  • PTGX 5.0B
  • ACIW 5.3B
  • IPO Year
  • PTGX 2016
  • ACIW 1995
  • Fundamental
  • Price
  • PTGX $85.30
  • ACIW $46.69
  • Analyst Decision
  • PTGX Strong Buy
  • ACIW Strong Buy
  • Analyst Count
  • PTGX 9
  • ACIW 3
  • Target Price
  • PTGX $86.44
  • ACIW $60.00
  • AVG Volume (30 Days)
  • PTGX 912.3K
  • ACIW 723.1K
  • Earning Date
  • PTGX 11-06-2025
  • ACIW 11-06-2025
  • Dividend Yield
  • PTGX N/A
  • ACIW N/A
  • EPS Growth
  • PTGX N/A
  • ACIW 16.89
  • EPS
  • PTGX 0.72
  • ACIW 2.47
  • Revenue
  • PTGX $209,217,000.00
  • ACIW $1,731,220,000.00
  • Revenue This Year
  • PTGX N/A
  • ACIW $10.58
  • Revenue Next Year
  • PTGX $140.23
  • ACIW $6.86
  • P/E Ratio
  • PTGX $117.38
  • ACIW $18.98
  • Revenue Growth
  • PTGX N/A
  • ACIW 7.01
  • 52 Week Low
  • PTGX $33.31
  • ACIW $40.45
  • 52 Week High
  • PTGX $93.25
  • ACIW $59.71
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 66.16
  • ACIW 39.64
  • Support Level
  • PTGX $76.70
  • ACIW $47.14
  • Resistance Level
  • PTGX $86.90
  • ACIW $52.28
  • Average True Range (ATR)
  • PTGX 3.20
  • ACIW 1.46
  • MACD
  • PTGX 0.30
  • ACIW -0.13
  • Stochastic Oscillator
  • PTGX 83.71
  • ACIW 5.11

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About ACIW ACI Worldwide Inc.

ACI Worldwide Inc develops, markets and installs a portfolio of software products focused on facilitating electronic payments. The firm also leverages its distribution network in the Americas; Europe, the Middle East, and Africa, or EMEA; and Asia-Pacific regions to sell software developed by third parties. ACI software products process payment transactions for retail banking clients, billers such as utilities and healthcare providers, and community banks and credit unions. ACI's customers are financial institutions all over the world, but majority of the revenue is generated in the United States and EMEA regions.

Share on Social Networks: